Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference Kisspeptin 5mg FOR RESEARCH
Phase II Evidence Stage
Sexual Wellness Primary Domain
Subcutaneous or intravenous injection Routes Studied
200+ PubMed Citations
Sexual Peptide
Preclinical-Promising

Kisspeptin

Synthetic peptide studied in animal and cell models for hpg axis activation and physiological gonadotropin pattern

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
Kisspeptin
Class
Sexual Wellness peptide
Summary
Synthetic peptide studied in animal and cell models for hpg axis activation, physiological gonadotropin pattern, neuroendocrine-behavioral integration.
Mechanism
Gonadal Steroidogenesis & Gametogenesis
Research Status
Phase II
Routes Studied
Subcutaneous or intravenous injection
Evidence Level
Preclinical-promising · Clinically unproven
[ QUICK.ANSWERS ]

What Should You Know About Kisspeptin?

What is Kisspeptin?
Kisspeptin is a synthetic peptide studied in animal and cell models for hpg axis activation and physiological gonadotropin pattern.
Is Kisspeptin clinically proven?
No. Human evidence remains limited and does not establish Kisspeptin as clinically proven.
What has Kisspeptin been studied for?
Kisspeptin has been studied in preclinical models of hpg axis activation, physiological gonadotropin pattern, neuroendocrine-behavioral integration. These findings have not been confirmed in large-scale human trials.
Is Kisspeptin approved?
No. Kisspeptin is not an approved drug and remains a research compound.
[ COMPOUND.PROFILE ]

What Is Kisspeptin?

Kisspeptin refers to a family of neuropeptides derived from the proteolytic cleavage of the 145-amino acid precursor protein encoded by the KISS1 gene, originally identified in 1996 as a metastasis suppressor gene at Penn State University in Hershey, Pennsylvania (hence the chocolate-themed naming convention). The primary bioactive forms include Kisspeptin-54 (the full-length mature peptide, also known as metastin), Kisspeptin-14, Kisspeptin-13, and Kisspeptin-10, all sharing the same C-terminal decapeptide sequence (Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2)...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Preclinical-promising · Clinically unproven

Kisspeptin is a research compound with promising biological signals but limited human validation. Most claims exceed current clinical evidence.

Evidence Breakdown

Domain Evidence Level
HPG Axis Activation Limited
Physiological Gonadotropin Pattern Limited
Neuroendocrine-Behavioral Integration Limited
Metabolic Integration Limited
Human clinical evidence Limited
Safety data Insufficient

Editorial Position

Kisspeptin is best understood as a compound with emerging clinical evidence that has not yet reached definitive conclusions. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.

Regulatory Status Snapshot

  • Not approved as a therapeutic drug by major regulators
  • Safety profile not established in large human populations

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has Kisspeptin Been Studied For?

Research areas where Kisspeptin has been investigated in published studies

  • HPG Axis Activation Kisspeptin has been studied in animal models of hpg axis activation. These findings have not been confirmed in controlled human trials.
  • Physiological Gonadotropin Pattern Kisspeptin has been studied in animal models of physiological gonadotropin pattern. These findings have not been confirmed in controlled human trials.
  • Neuroendocrine-Behavioral Integration Kisspeptin has been studied in animal models of neuroendocrine-behavioral integration. These findings have not been confirmed in controlled human trials.
  • Metabolic Integration Kisspeptin has been studied in animal models of metabolic integration. These findings have not been confirmed in controlled human trials.
[ MECHANISM ]

How Does Kisspeptin Work?

These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.

  1. 01 KISS1R Receptor Binding
  2. 02 Intracellular signaling
  3. 03 GnRH Pulsatile Release
  4. 04 Gonadotropin Secretion
NEXT STEP

Not sure if Kisspeptin is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about Kisspeptin.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate Kisspeptin

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is Kisspeptin Administered?

Kisspeptin is available via Subcutaneous or intravenous injection. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of Kisspeptin?

Format Lyophilized Powder
Amount 5mg per vial
Purity >98%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (Kisspeptin-10, minimal bioactive sequence)
Molecular Weight 1302.5 g/mol (Kisspeptin-10)
Storage Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light.
Appearance White to off-white lyophilized powder
[ EXPLORE ]

What Conditions Has Kisspeptin Been Linked To?

Have Questions About Kisspeptin?

Research using functional brain imaging (fMRI) has shown that kisspeptin administration modulates neural activity in brain regions associated with sexual arousal, emotional processing, and reward (including the amygdala and cingulate cortex).

Published studies on Kisspeptin can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

Kisspeptin is available as a research compound in Thailand. Consult a qualified specialist to discuss whether it is appropriate for your needs.

Ready to discuss Kisspeptin with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.